I-3-Cyanoindole CAS 5457-28-3 Purity ≥98.0% (HPLC) Isithombe Esifakiwe Sefektri Sekhwalithi Ephezulu

I-3-Cyanoindole CAS 5457-28-3 Purity ≥98.0% (HPLC) Ifektri Yekhwalithi Ephezulu

Incazelo emfushane:

Igama Lekhemikhali: 3-Cyanoindole

I-CAS: 5457-28-3

Ubumsulwa: ≥98.0% (HPLC)

Ukubukeka: Okuphuzi Okuphaphathekile ukuya Kokuphuzi I-Crystalline Powder

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomphakeli we-3-Cyanoindole (CAS: 5457-28-3) enekhwalithi ephezulu, ukukhiqizwa kwezentengiso.Wamukelekile eku-odeni.

Chemical Properties:

Igama Lekhemikhali	3-Cyanoindole
Omqondofana	1H-Indole-3-Carbonitrile;Indole-3-Carbonitrile;3-Indolecarbonitrile
Inombolo ye-CAS	5457-28-3
Inombolo yeCAT	I-RF-PI1534
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C9H6N2
Isisindo samangqamuzana	142.16
Ukuncibilika kwamanzi	Ayincibiliki Emanzini
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Eyikristalu Ephuzi Ephuzi ukuya Ephuzi
Ukuhlanzeka / Indlela Yokuhlaziya	≥98.0% (HPLC)
I-Melting Point	178.0~181.0℃
Amanzi (KF)	≤0.50%
Ukungcola Okuphelele	≤2.00%
1 H NMR Spectrum	Ihambisana Nesakhiwo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-3-Cyanoindole (i-CAS: 5457-28-3) iyinhlanganisela ewusizo ku-organic synthesis.Isabela ekulungiseleleni: I-Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles njengama-immunomodulators angaba khona e-anticancer;Ama-inhibitors wesizinda se-C-terminal se-RNA polymerase II enemisebenzi yokulwa nesimila Isebenza ngokuphila;Ama-Indoles Inhibitors we-glycogen synthase kinase 3β (GSK-3);I-HIV-1 integrase inhibitors;Izingcezu ze-Indole njengama-inosine monophosphate dehydrogenase (IMPDH) inhibitors;i-Aziridinomitosene skeleton;Ama-antiviral angaba khona.